Fibrosis, scar, and related structural abnormalities can disrupt uniform activation by slowing conduction through affected tissue. As electrical activity reaches an electrode through altered or separated conduction pathways, the recorded signal may contain several temporally distinct deflections rather than one dominant event. This electrogram pattern helps reveal regions where conduction is spatially and temporally disorganized.
Low-amplitude, fragmented signals can indicate that the electrode is recording from tissue with abnormal conduction rather than a uniformly activated region. Their presence therefore provides an electrical marker of potential disease-related substrate. In cardiac electrophysiology, recognizing these patterns helps clinicians focus attention on conduction pathways that may be associated with atrial or ventricular arrhythmias.
A single sharp electrogram is consistent with a more uniform activation event at the recording site, whereas multiple deflections suggest that activation is arriving in a less coordinated manner. The contrast is useful because it links the recorded waveform to the underlying tissue condition. Comparing signal patterns across regions can support identification of abnormal conduction substrates.
The same electrophysiological concern, nonuniform activation associated with structural abnormality, can arise in tissue involved in either atrial or ventricular arrhythmias. Consequently, these signals are used to map substrates in both chambers rather than being restricted to one arrhythmia category. This broad relevance supports their role in evaluating different cardiac conduction disorders.
During cardiac electrophysiology procedures, clinicians record and map electrical activity to locate areas containing abnormal signal patterns. Regions with fractionated potentials can help identify diseased conduction pathways or arrhythmia-associated substrates. That information guides catheter ablation by helping target tissue considered relevant to the abnormal electrical circuit or substrate.
Mapping can show where abnormal conduction patterns are distributed within cardiac tissue and whether they correspond to a suspected atrial or ventricular arrhythmia substrate. The resulting electrical map adds functional information to the presence of structural disease, helping clinicians characterize the regions most relevant to treatment planning and catheter-based intervention.
Current research examines whether the presence and characteristics of these signals can help predict treatment response and the likelihood that an arrhythmia will recur. This work extends their role beyond immediate substrate localization. If validated, such information could improve interpretation of electrophysiological maps and help relate recorded signal patterns to outcomes after intervention.